Microglial cerebrospinal fluid antibodies: Significance for Alzheimer disease

Molecular and Chemical Neuropathology

Volumn 28, Issue 1-3, 1996, Pages 89-95

  Mcrae, Amanda ^a   Ling, Eng Ang ^b   Wigander, Annelie ^a   Dahlström, Annica ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alzheimer disease; antibodies; cerebrospinal fluid; diagnosis; immune responses; microglia; rat brain

Indexed keywords

ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; CELL CULTURE; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; DEMENTIA; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENCE; MICROGLIA; NERVE DEGENERATION; PRIORITY JOURNAL; RELIABILITY;

EID: 0029815972     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815209     Document Type: Conference Paper

References (23)

1. Baidinger S. and Blumenthal H. T. (1982) Neuroimmunology of the aging brain, in Geriatrics (Platt D, ed.), Springer Verlag, Berlin, Germany, pp. 283-299.
2. Banati R. B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., and Kreutzberg G. W. (1994) Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J. Cereb. Blood Flow Metab. 14, 145-149.
3. Cras P., Kawai M., Siedlak S., and Perry G. (1991) Microglia are associated the extracellular neurofibrillary tangles of Alzheimer's disease. Brain Res. 558, 312-314.
4. Dahlström A., McRae A., Polinsky R., Nee L., Sadasivan B., and Ling E. A. (1994) Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia investigations with cell cultures and human cortical biopsies. Molecular Neurobiology 9, 41-54.
5. Dahlström A., Wigander A., Lundmark K., Gottfries C. G., and McRae A. (1990) Investigations on autoantibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J. Neural Trans. (suppl) 29, 195-206.
6. Fudenberg H. H. and Singh V. (1988) Alzheimer's "Syndrome": Prognosis of subsets with different etiology and preliminary effects of immunotherapy. Drug Dev. Res. 15, 165-174.
7. Guilian D. (1987) Ameoboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18, 155-171.
8. Haga S., Akai K., and Ishii T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. 77, 569-575.
9. Ling E. A. and Wong W. C. (1993) The origin and nature of ramified and ameoboid microglia: A historical review and current concepts. Glia 7, 9-18.
10. Ling E. A., Kaur C., Yick T., and Wong W. (1990) Immunocytochemical localization of CR3 complement receptors with OX 42 in amoeboid microglia in postnatal rats. Anat. Embryol. 182, 481-486.
11. Ling E. A., Dahlström A., Polinsky R., Nee L., and McRae A. (1992a) Studies of activated microglia cells and macrophages using Alzheimer's disease cerebrospinal fluid in adult rats with experimentally induced lesions. Neuroscience 51, 815-825.
12. Ling E. A., Kaur C., and Wong W. C. (1992b) Expression of major histocompatibility complex antigens and CR3 complement receptors in activated microglia following an injection of ricin into the sciatic nerve in rats. Histol. Histopath 7, 93-100.
13. McGeer P. and Rogers J. (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42, 447-449.
14. McGeer P., Itagaki S., Tago H., and McGeer E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer's type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195-200.
15. McGeer P. L., Akiyama H., Itagaki S., and McGeer E. G. (1989) Immune system response in Alzheimer's disease. Can J. Neurol. Sci. 16, 516-527.
16. McRae A., Blennon K., Gottfries C. G., Walin A., and Dahlström A. (1990) Brain specific antibodies in the CSF of patients with Alzheimer's disease and other types of dementias, in Biological Markers in Dementia of Alzheimer Type (Fowler C. J., Carlson L. A., Gottfries C. G., and Winblad B., eds.), Smith-Gordon, London, pp. 135-148.
17. McRae A., Ling E. A., Polinsky R., Gottfries C. G., and Dahlström A. (1991) Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system. Neuroscience 41, 739-752.
18. McRae A., Rudolphi K., and Keil M. (1993) Forebrain ischemia in monogolian gerbil: a model to investigate Alzheimer's disease microglial antibodies and amyloid, Soc. Neurosci. Abstract 19, 623.
19. McRae A., Rudolphi K. A., and Schubert P. (1994) Propentofylline depresses amyloid and Alzheimer's CSF microglial antigens after ischemia, NeuroReport 5, 1193-1196.
20. Morioka T., Kalehua A. N. and Streit W. J. (1992) Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia, Acta Neuropathol. 83, 149-157.
21. Rio-Hertega P. del. (1932) Microglial, in Cytology and Cellular Pathology of the Nervous System, Vol. 2 (Penfield W., ed.), Paul B Hoeber, New York, pp. 481-584.
22. Rogers J., Luber-Narod J., Styren S., and Civin H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9, 339-349.
23. Selkoe D., Ihara Y., and Salazar F. J. (1982) Alzheimer's disease: Insolubility of partially purified paired filaments helical in sodium dodecyl sulfate and urea. Science 215, 1243-1245.